Osteoporosis Canada advises individuals on denosumab therapy to discuss their treatment with their physician prior to delaying therapy, stopping therapy or missing a scheduled dose.   Denosumab (Prolia) has been […]

Available Volunteer Opportunities Bone Health Education Presenter – Virtual Bone Health Education Volunteers work together with the Community Engagement Coordinators and are an integral part in the planning and facilitating […]

BC ADVOCACY Osteoporosis Canada together with British Columbia Coalition of Osteoporosis Physicians (BCCOP) and Medicines Access Coalition – BC (MedAccess BC) are working together to advocate for British Columbians at […]

  Our Financials YEAR ENDED MARCH 31, 2022 Osteoporosis Canada’s Program Fund, which accounts for revenue and expenses related to education, advocacy and awareness, administration, and fundraising, had a year-end […]

On September 29, 2015, two research articles were published online in the British Medical Journal (BMJ) concerning the effect of calcium intake on bone mineral density (BMD) and fracture reduction. […]

Available Volunteer Opportunities Support Group Facilitator – Virtual Support Group Facilitators work together with the Community Engagement Coordinators and are an integral part in the delivery of support services. Groups […]

There is no excerpt because this is a protected post.

Medications that can Cause Bone Loss, Falls and/or Fractures A variety of medications can increase bone loss and/or fall risk: Synthetic Glucocorticoids (e.g. Prednisone) Glucocorticoids are produced naturally by the […]